VR Discharge Education After Prostatectomy

NCT07507123 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2026-04-02

No results posted yet for this study

Summary

This randomized controlled trial aimed to evaluate the effect of virtual reality-based discharge education on patients' readiness for hospital discharge after prostatectomy. Patients were randomly assigned to either a virtual reality-based education group or a control group receiving standard discharge education. The intervention provided immersive and interactive learning experiences to enhance patients' understanding of post-discharge care. Readiness for hospital discharge was assessed using a validated scale. It is anticipated that patients receiving virtual reality-based education will demonstrate higher levels of readiness compared to those receiving standard education. The findings may support the integration of innovative educational technologies into postoperative patient education to improve discharge outcomes.

Conditions

  • Discharge Education
  • Prostatectomy

Interventions

OTHER

Discharge Education

Intervention Group: Virtual Reality-Based Discharge Education In addition to standard perioperative education, patients in the intervention group received a virtual reality-based educational intervention before surgery. This intervention was delivered in the urology clinic's procedure room using VR headsets and consisted of an approximately structured educational video covering postoperative care and discharge-related information. The aim was to provide an immersive and interactive learning experience to enhance patient understanding and preparedness. As in the control group, readiness for hospital discharge was assessed prior to discharge using the same validated instrument.

Sponsors & Collaborators

  • Aydin Adnan Menderes University

    lead OTHER

Principal Investigators

  • HiLAL H ÜLKÜ, PhD · Aydin Adnan Menderes University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-15
Primary Completion
2024-11-15
Completion
2024-11-15

Countries

  • Turkey (Türkiye)

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07507123 on ClinicalTrials.gov